Circulating levels of IGF-1 have been shown to be similar between people with COPD and controls across disease severities (Piehl-Aulin et al., 2009) and in cachetic vs. non-cachetic patients with COPD (Debigare et al., 2003). Here, IGF1 is linked to chronic obstructive pulmonary disease.